These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
198 related items for PubMed ID: 1964667
1. Mode of action of unfractionated and low molecular weight heparins on the generation of thrombin in plasma. Hemker HC, Béguin S. Haemostasis; 1990; 20 Suppl 1():81-92. PubMed ID: 1964667 [Abstract] [Full Text] [Related]
2. An approach to assigning in vitro potency to unfractionated and low molecular weight heparins based on the inhibition of prothrombin activation and catalysis of thrombin inhibition. Ofosu FA, Smith LM, Anvari N, Blajchman MA. Thromb Haemost; 1988 Oct 31; 60(2):193-8. PubMed ID: 2851191 [Abstract] [Full Text] [Related]
3. Mode of action of enoxaparin in plasma. Béguin S, Hemker HC. Acta Chir Scand Suppl; 1990 Oct 31; 556():51-6. PubMed ID: 1963017 [Abstract] [Full Text] [Related]
4. Comparative inhibition of LPS-activated human monocyte-induced thrombin generation by unfractionated heparin and low molecular weight heparins. Nguyên P, Rémy MG, Potron G. Haemostasis; 1999 Oct 31; 29(6):301-9. PubMed ID: 10844403 [Abstract] [Full Text] [Related]
5. Inhibition of thrombin generation by heparin and low molecular weight (LMW) heparins in the absence and presence of platelet factor 4 (PF4). Padilla A, Gray E, Pepper DS, Barrowcliffe TW. Br J Haematol; 1992 Oct 31; 82(2):406-13. PubMed ID: 1329921 [Abstract] [Full Text] [Related]
6. Mechanisms for the antithrombotic activity in man of low molecular weight heparins (LMWHs). Samama MM, Bara L, Gerotziafas GT. Haemostasis; 1994 Oct 31; 24(2):105-17. PubMed ID: 7959358 [Abstract] [Full Text] [Related]
7. Antithrombotic activity and its relationship to in vitro anticoagulant effects. Gray E, Padilla A, Barrowcliffe TW. Haemostasis; 1993 Mar 31; 23 Suppl 1():99-102. PubMed ID: 8388358 [Abstract] [Full Text] [Related]
8. Determination of the levels of unfractionated and low-molecular-weight heparins in plasma: their effect on thrombin-mediated feedback reactions in vivo. Preliminary results after subcutaneous injection. Hemker HC, Béguin S, Bendetowicz AV, Wielders S. Haemostasis; 1991 Mar 31; 21(4):258-72. PubMed ID: 1665467 [Abstract] [Full Text] [Related]
9. Heparin and low molecular weight heparins inhibit prothrombinase formation but not its activity in plasma. Ofosu FA, Lormeau JC, Craven S, Dewar L, Anvari N. Thromb Haemost; 1994 Dec 31; 72(6):862-8. PubMed ID: 7740455 [Abstract] [Full Text] [Related]
15. New data on the pharmacology of heparin and low molecular weight heparins. Samama MM, Bara L, Gouin-Thibault I. Drugs; 1996 Dec 31; 52 Suppl 7():8-14; discussion 14-5. PubMed ID: 9042555 [Abstract] [Full Text] [Related]
16. The inhibition of intrinsic prothrombinase and its generation by heparin and four derivatives in prothrombin poor plasma. Bendetowicz AV, Bara L, Samama MM. Thromb Res; 1990 Jun 01; 58(5):445-54. PubMed ID: 2164262 [Abstract] [Full Text] [Related]
17. Comparison of enoxaparin and unfractionated heparin on thrombin generation in acute coronary syndromes without ST-segment elevation. Salvioni A, Casilli F, Assanelli E, Grazi M, Marenzi G, Guazzi MD. Thromb Haemost; 2001 Oct 01; 86(4):991-4. PubMed ID: 11686357 [Abstract] [Full Text] [Related]